Advanced maternal age and assisted reproductive technologies: outcomes, genomics, and real-world evidence
Pregnancies from AMA + ART should be managed as high risk. Integration of genomics technologies and RWD can support predictive, personalized care and inform urgently needed consensus guidelines.
Authors
- María Jesús Fernández Sánchez (ORCID: https://orcid.org/0000-0003-3891-8872)
- Marta Domínguez-Moreno (ORCID: https://orcid.org/0000-0001-8010-9628)
- Cristina Méndez‐Vidal
- J. Dopazo
- L. García-Díaz
- G. Antiñolo
Institutions
- Fundación Progreso y Salud (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Instituto de Biomedicina de Sevilla (ES)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- Frontiers in Reproductive Health
- Published
- 2026-02-26
- DOI
- https://doi.org/10.3389/frph.2026.1787867
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00